180 related articles for article (PubMed ID: 31930532)
1. Successful treatment of refractory Hailey-Hailey disease with apremilast.
Di Altobrando A; Sacchelli L; Patrizi A; Bardazzi F
Clin Exp Dermatol; 2020 Jul; 45(5):604-605. PubMed ID: 31930532
[No Abstract] [Full Text] [Related]
2. Apremilast in benign chronic pemphigus (Hailey-Hailey disease).
Riquelme-Mc Loughlin C; Iranzo P; Mascaró JM
Clin Exp Dermatol; 2020 Aug; 45(6):737-739. PubMed ID: 32198945
[No Abstract] [Full Text] [Related]
3. Treatment of Severe Hailey-Hailey Disease With Apremilast.
Kieffer J; Le Duff F; Montaudié H; Chiaverini C; Lacour JP; Passeron T
JAMA Dermatol; 2018 Dec; 154(12):1453-1456. PubMed ID: 30304341
[TBL] [Abstract][Full Text] [Related]
4. Combination of dermabrasion and Apremilast for Hailey-Hailey disease.
Siliquini N; Deboli T; Marchetti Cautela J; Mangia A; Fraccalvieri M; Dapavo P; Quaglino P; Ribero S
Ital J Dermatol Venerol; 2021 Dec; 156(6):727-728. PubMed ID: 32129590
[No Abstract] [Full Text] [Related]
5. Old drug, new tricks - successful treatment of Hailey-Hailey disease with thalidomide.
Kearney N; Raichura S; Houghton J; O'Kane D
Australas J Dermatol; 2021 Feb; 62(1):94-96. PubMed ID: 33070308
[No Abstract] [Full Text] [Related]
6. Apremilast in combination with botulinum toxin-A injection for recalcitrant Hailey-Hailey disease.
Antoñanzas J; Tomás-Velázquez A; Rodríguez-Garijo N; Estenaga Á; Salido-Vallejo R
Int J Dermatol; 2022 May; 61(5):600-602. PubMed ID: 34705274
[No Abstract] [Full Text] [Related]
7. Synergistic cytokine effects as apremilast response predictors in patients with psoriasis.
Garcet S; Nograles K; Correa da Rosa J; Schafer PH; Krueger JG
J Allergy Clin Immunol; 2018 Sep; 142(3):1010-1013.e6. PubMed ID: 29936103
[No Abstract] [Full Text] [Related]
8. A Case of Pityriasis Rubra Pilaris Treated Successfully with the Phosphodiesterase-4 Inhibitor Apremilast.
Cho M; Honda T; Ueshima C; Kataoka T; Otsuka A; Kabashima K
Acta Derm Venereol; 2018 Nov; 98(10):975-976. PubMed ID: 29944172
[No Abstract] [Full Text] [Related]
9. Apremilast for the management of moderate to severe plaque psoriasis.
Vangipuram R; Alikhan A
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):349-360. PubMed ID: 28276777
[TBL] [Abstract][Full Text] [Related]
10. Real-world, single-centre experience of apremilast for the treatment of moderate to severe psoriasis.
Wong TH; Sinclair S; Smith B; Fraser C; Morton CA
Clin Exp Dermatol; 2017 Aug; 42(6):675-676. PubMed ID: 28621002
[No Abstract] [Full Text] [Related]
11. Chronic tearing induced by apremilast.
Norris MR; Bielory L
Ann Allergy Asthma Immunol; 2018 Sep; 121(3):375. PubMed ID: 29969663
[No Abstract] [Full Text] [Related]
12. Two cases of Hailey-Hailey disease effectively treated with apremilast and a review of reported cases.
Yoto A; Makino T; Mizawa M; Matsui Y; Takemoto K; Furukawa F; Kataoka K; Nakano H; Sawamura D; Shimizu T
J Dermatol; 2021 Dec; 48(12):1945-1948. PubMed ID: 34569085
[TBL] [Abstract][Full Text] [Related]
13. Vesiculobullous Hailey-Hailey disease: successful treatment with oral retinoids.
Hunt MJ; Salisbury EL; Painter DM; Lee S
Australas J Dermatol; 1996 Nov; 37(4):196-8. PubMed ID: 8961587
[TBL] [Abstract][Full Text] [Related]
14. Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial.
Ohtsuki M; Okubo Y; Komine M; Imafuku S; Day RM; Chen P; Petric R; Maroli A; Nemoto O
J Dermatol; 2017 Aug; 44(8):873-884. PubMed ID: 28391657
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast.
Krase IZ; Cavanaugh K; Curiel-Lewandrowski C
JAMA Dermatol; 2016 Mar; 152(3):348-50. PubMed ID: 26536384
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis.
Pathan E; Abraham S; Van Rossen E; Withrington R; Keat A; Charles PJ; Paterson E; Chowdhury M; McClinton C; Taylor PC
Ann Rheum Dis; 2013 Sep; 72(9):1475-80. PubMed ID: 22984171
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of Hailey-Hailey disease with acitretin.
Berger EM; Galadari HI; Gottlieb AB
J Drugs Dermatol; 2007 Jul; 6(7):734-6. PubMed ID: 17763599
[TBL] [Abstract][Full Text] [Related]
18. Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease.
Sand C; Thomsen HK
Arch Dermatol; 2003 Nov; 139(11):1401-2. PubMed ID: 14623698
[No Abstract] [Full Text] [Related]
19. Trial of Apremilast for Oral Ulcers in Behçet's Syndrome.
Hatemi G; Mahr A; Ishigatsubo Y; Song YW; Takeno M; Kim D; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
N Engl J Med; 2019 Nov; 381(20):1918-1928. PubMed ID: 31722152
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis.
Bianchi L; Del Duca E; Romanelli M; Saraceno R; Chimenti S; Chiricozzi A
Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):1121-8. PubMed ID: 27376729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
